Nature contains a treasure trove of substances that could help fight human disease. Just this year, the Nobel Prize in Physiology or Medicine honored the development of drugs that fight parasites and malaria based on such “natural products.”
But finding these molecules and discovering new chemical identities represents slow and painstaking work. This week in ACS Central Science, researchers report a new way to greatly speed up that process.
Current methods for sussing out new molecules are much like casting a fishing line in a vast ocean. And once a compound is on the hook, there’s still much more work to be done to find out what it looks like and, ideally, how it is made. Because bacteria and other organisms make natural products using protein-based assembly lines, the genes that encode for them cluster together in the genome, making them easier to recognize. So, Neil Kelleher, William Metcalf and colleagues surmised that if they evaluated the amount of various natural products and compared that to the abundance of these assembly lines, they could determine which genes produced which natural products for many dozens of cases in parallel.
To demonstrate the new approach, the authors sequenced the genomes of 178 different strains of a bacterial family called the actinomycetes, while also measuring the amounts of the natural products made by each strain using mass spectrometry. When a natural product and a gene cluster involved in an assembly line were frequently found together in different species of bacteria, they scored this co-occurrence and inferred that they go together. This technique allowed the team to identify a new natural product they called tambromycin, along with its cellular machinery. Interestingly, Drug discovery with natural moleculesfeatures a previously unknown amino acid they called tambroline, and the team showed it could slow the growth of two types of leukemia without affecting healthy cells.
The authors note that their method improves with the number of strains interrogated and will standardize access to thousands of new lead compounds to reinvigorate drug discovery pipelines with natural molecules.
Read more: Gone fishin’ for natural products, with a new dragnet
The Latest on: Drug discovery with natural molecules
[google_news title=”” keyword=”Drug discovery with natural molecules” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug discovery with natural molecules
- Optical barcodes expand range of high-resolution sensoron April 26, 2024 at 11:27 am
The same geometric quirk that lets visitors murmur messages around the circular dome of the whispering gallery at St. Paul's Cathedral in London or across St. Louis Union Station's whispering arch ...
- New prototype that regenerates stem cells may repair IPF scarringon April 26, 2024 at 10:42 am
Researchers developed NZ-97, an inhalable drug that stimulates the growth of stem cells in the lungs, potentially repairing scarring in IPF.
- Artificial Intelligence Helps Scientists Engineer Plants to Fight Climate Changeon April 25, 2024 at 3:16 pm
Deep learning software called SLEAP used to analyze plant features, accelerating design of climate-saving plants ...
- The Difference Is the Data: Drug Discovery’s AI Revolutionon April 25, 2024 at 4:00 am
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
- Vast DNA tree of life for plants revealed by global science team using 1.8 billion letters of genetic codeon April 24, 2024 at 8:00 am
A new paper published today (April 24) in the journal Nature by an international team of 279 scientists led by the Royal Botanic Gardens, Kew presents the most up-to-date understanding of the ...
- AI is boosting drug discovery and development — and sparking questions about proprietary dataon April 23, 2024 at 1:51 pm
AI and Biotech panel at Life Science Innovation Northwest 2024. From left: Danielle Greenawalt, Lynda Stuart, Sean McClain, Jonathan Cohen and moderator ...
- New copper-catalyzed C-H activation strategyon April 20, 2024 at 2:02 pm
Inspired by what human liver enzymes can do, chemists have developed a new set of copper-catalyzed organic synthesis reactions for building and modifying pharmaceuticals and other molecules. The new ...
- Chemists introduce new copper-catalyzed C-H activation strategyon April 19, 2024 at 11:24 am
Inspired by what human liver enzymes can do, Scripps Research chemists have developed a new set of copper-catalyzed organic synthesis reactions for building and modifying pharmaceuticals and other ...
- Launch Minnesota awards $673K in grants to 26 startupson April 17, 2024 at 4:23 am
Launch Minnesota, an initiative to grow Minnesota's startup ecosystem through the Minnesota Department of Employment and Economic Development, awarded 26 Minnesota-based startups a total of $673,280 ...
- Innovating drug development: Charles River embracing alternatives to animal testingon April 16, 2024 at 7:39 am
Charles River Laboratories International, Inc. has unveiled its Alternative Methods Advancement Project (AMAP), a strong initiative aimed at changing drug discovery and development by exploring ...
via Bing News